GEIST:UPC Searchengine

ORD_58802/2024

Pfizer Manufacturing Belgium S.A, Pfizer Inc, Pfizer Europe MA EEIG, Pfizer S.A, Pfizer Ltd, Pfizer Pharma GmbH, Pfizer Service Company S.R.L., Pfizer B.V. v. GlaxoSmithKline Biologicals S.A.

Datum
2024-12-03
Kammer
Milan (IT) Central Division- Section
Verfahrensart
Preliminary objection
Sprache
EN

Metadaten

Fall-IDORD_58802-2024-84b96b9f2397
Aktenzeichen
RegisterzeichenORD_58802/2024
EntscheidungsreferenzORD_58802/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 12

1 Milan - Central Division - First Instance - central division UPC_CFI_476/2024 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 02/12/2024 Date of receipt of Statement of revocation : Not provided GlaxoSmithKline Biologicals S.A. (Defendant) - Rue de l Institut 89 - 1330 - Rixensart - BE Statement of revocation served on 16/09/2024 REFERENCE CODE ECLI: Not provided APPLICANT/S 1) GlaxoSmithKline Biologicals S.A. (Applicant) - Rue de l Institut 89 - 1330 - Rixensart – BE Represented by Daniela Kinkeldey RESPONDENT/S 1) Pfizer Inc (Respondent) - 66 Hudson Boulevard East - NY 10001-2192 - New York – US Represented by Gareth Owen Williams 2) Pfizer Europe MA EEIG (Respondent) - Boulevard de la Plaine 17 - 1050 - Ixelles – BE 2 3) Pfizer B.V. (Respondent ...